Concepedia

Publication | Closed Access

Angiotensin II type 1 receptor antagonist as an angiogenic inhibitor in prostate cancer

96

Citations

30

References

2006

Year

Abstract

Candesartan exerted preventive effects on HRPC, rather than on androgen-sensitive PCa, through the inhibition of tumor angiogenesis.

References

YearCitations

Page 1